p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo

Citation
Dy. Wang et al., p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo, J CELL SCI, 113(23), 2000, pp. 4221-4230
Citations number
44
Categorie Soggetti
Cell & Developmental Biology
Journal title
JOURNAL OF CELL SCIENCE
ISSN journal
00219533 → ACNP
Volume
113
Issue
23
Year of publication
2000
Pages
4221 - 4230
Database
ISI
SICI code
0021-9533(200012)113:23<4221:PFAKPM>2.0.ZU;2-0
Abstract
p125 focal adhesion kinase (p125FAK) is a cytoplasmic tyrosine kinase that is activated upon engagement of integrin cell adhesion receptors, and initi ates several signaling events that modulate cell function in vitro. To dete rmine the biologic role of p125FAK in malignant astrocytic tumor cells, U-2 51MG human malignant astrocytoma cells were stably transfected with p125FAK cDNA using the TET-ON system, and stable clones isolated that exhibited an estimated 5- or 20-fold increase in p125FAK expression on administration o f 0.1 or 2.0 mug/ml doxycycline, respectively, In vitro studies demonstrate d that induction of p125FAK resulted in a 2- to 3-fold increase in cell mig ration, increased p130CAS phosphorylation, localization of exogenous p125FA K to focal adhesions, and a 2-fold increase in soft agar growth. To determi ne the role of p125FAK in vivo, clones were injected stereotactically into the brains of scid mice. A 4.5-fold estimated increase in p125FAK expressio n was induced by administration of doxycycline in the drinking water. Analy sis of xenograft brains demonstrated that, upon induction of p125FAK, there was a 1.6- to 2.8-fold increase in tumor cell number, and an increase in m Ab PCNA-labeling of tumor cells in the absence of a change in the apoptotic index. Compared to normal brain, the expression of p125FAK was elevated in malignant astrocytic tumor biopsies from patient samples, These data demon strate for the first time that p125FAK promotes tumor cell proliferation in vivo, and that the underlying mechanism is not associated with a reduction in apoptosis.